secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001104659-25-015015
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie issues $4B in senior notes across four maturities to refinance near-term debt
--------------------------------------------------------------------------------

- Issued $1.25B 4.650% notes due 2028, $1B 4.875% due 2030, $1B 5.200% due 2035, $750M 5.600% due 2055.
- Net proceeds ~$3.98B after underwriting discounts and expenses.
- Proceeds plus cash on hand to repurchase or repay $3.75B 3.600% notes due May 2025 and/or $2.89B 3.800% notes due March 2025.
- Closing expected February 26, 2025; underwriters include BofA, J.P. Morgan, Morgan Stanley, Barclays, Mizuho.
- Offering also includes refinancing of $130M Allergan Funding 3.800% notes due March 2025 or general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/0001104659-25-015015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465925015015/tm255723d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-015015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer